These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 9469236)

  • 1. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B; Benfield P
    Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M; Nardi AE; Figueira IL; Stabl M
    Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analytical studies on new antidepressants.
    Anderson IM
    Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide: therapeutic use and clinical studies.
    Bonnet U
    CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M; Biziére K; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
    Nair NP; Ahmed SK; Kin NM; West TE
    Acta Psychiatr Scand Suppl; 1995; 386():28-35. PubMed ID: 7717092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of depression. Part 2. The place of the new antidepressants.
    Mitchell PB; Mitchell MS
    Aust Fam Physician; 1994 Sep; 23(9):1771-3, 1776-81. PubMed ID: 7980178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants versus placebo for depression in primary care.
    Arroll B; Elley CR; Fishman T; Goodyear-Smith FA; Kenealy T; Blashki G; Kerse N; Macgillivray S
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007954. PubMed ID: 19588448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological therapy of dysthymia.
    Lapierre YD
    Acta Psychiatr Scand Suppl; 1994; 383():42-8. PubMed ID: 7942067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
    Goldberg RJ
    Drugs Aging; 1997 Aug; 11(2):119-31. PubMed ID: 9259175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y; Guelfi JD
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
    Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antidepressants: use in high-risk patients.
    Hale AS
    J Clin Psychiatry; 1993 Aug; 54 Suppl():61-70; discussion 71-3. PubMed ID: 8253707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.